 "Cipla Q2FY26 results: Net profit rises 3.7% to ₹1,353 cr on higher revenue")
Pharma major Cipla Ltd on Thursday reported a 3.7 per cent rise in consolidated net profit at ₹1,353.37 crore for the second quarter ended September 30, 2025.
The company had posted a consolidated net profit of ₹1,305.01 crore in the second quarter of the last fiscal year, Cipla Ltd said in a regulatory filing.
Consolidated total revenue from operations in the second quarter stood at ₹7,589.44 crore, as against ₹7,051.02 crore in the year-ago period, it added.
Total expenses in the quarter under review were higher at ₹6,004.86 crore, as compared to ₹5,452.57 crore in the corresponding period last fiscal, the company said.
In the second quarter, the pharmaceuticals segment clocked revenue of ₹7,291.43 crore, as against ₹6,775.56 crore in the same period a year ago.
New ventures registered revenue of ₹350.68 crore, as against ₹319.6 crore, the filing said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)